SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-17-001428
Filing Date
2017-03-07
Accepted
2017-03-07 16:59:48
Documents
74
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rigl-20161231x10k.htm 10-K 2471944
2 EX-10.38 rigl-20161231ex103819b40.htm EX-10.38 189230
3 EX-23.1 rigl-20161231ex231187141.htm EX-23.1 9442
4 EX-31.1 rigl-20161231ex311edf765.htm EX-31.1 12483
5 EX-31.2 rigl-20161231ex312cb4b41.htm EX-31.2 11768
6 EX-32.1 rigl-20161231ex321b00f0c.htm EX-32.1 8864
7 GRAPHIC rigl20161231x10k001.jpg GRAPHIC 20091
  Complete submission text file 0001558370-17-001428.txt   8833786

Data Files

Seq Description Document Type Size
8 EX-101.INS rigl-20161231.xml EX-101.INS 1858584
9 EX-101.SCH rigl-20161231.xsd EX-101.SCH 53993
10 EX-101.CAL rigl-20161231_cal.xml EX-101.CAL 48561
11 EX-101.DEF rigl-20161231_def.xml EX-101.DEF 201205
12 EX-101.LAB rigl-20161231_lab.xml EX-101.LAB 546650
13 EX-101.PRE rigl-20161231_pre.xml EX-101.PRE 386851
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29889 | Film No.: 17672718
SIC: 2834 Pharmaceutical Preparations